S&P 500 7,561.67 −0.40%
Nasdaq 25,136.27 −0.91%
S&P/TSX 36,105.90 −0.09%
Apple 356.27 +0.39%
Nvidia 162.85 −2.01%
Microsoft 523.88 +0.17%
Shopify 209.74 +0.16%
Royal Bank 288.37 −0.35%
CAD/USD 0.7008 −0.06%
CLOSED · 13:45 ET
Market ClerkRecap
Sat Nov 14 · markets closed3 signals today368 insider buys this week · $138.2MCIRO short report next: Nov 15The week ahead
BK
INSIDER · ORKA · Oruka Therapeutics, Inc. · DIRECTOR

BALL KRISTINE M

Every open-market transaction filed under this name, Nov 12 to Nov 12.

Filings
6
0 buys · 6 sells
Bought
—
open market, at cost
Sold
$1.9M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 12ORKAOruka Therapeutics, Inc.DirectorSell200$106.98$21K−10.2%
Nov 12ORKAOruka Therapeutics, Inc.DirectorSell2,500$106.05$265K−9.5%
Nov 12ORKAOruka Therapeutics, Inc.DirectorSell10,765$105.31$1.1M−8.8%
Nov 12ORKAOruka Therapeutics, Inc.DirectorSell2,039$104.16$212K−7.8%
Nov 12ORKAOruka Therapeutics, Inc.DirectorSell1,300$103.09$134K−6.9%
Nov 12ORKAOruka Therapeutics, Inc.DirectorSell1,196$102.10$122K−6.0%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.